Journals / Turkish Journal of Gastroenterology / 2005 / Cilt: 16 - Sayı: 2

Güney İran'da Wilson hastalığı

Wilson disease in Southern Iran

Pages
71–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Biochemical abnormalities were sometimes different in our patients in comparison to previous studies, possibly due to the delay in the diagnosis in our patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: Wilson disease is an autosomal recessive disorder of the brain, liver and cornea.
📊
Key Findings & Data:Methods: All the patients with Wilson disease who were admitted to Nemazee Hospital, Shiraz, Iran, from 1990 till 2004 were included in this cross-sectional descriptive study.
💡
Conclusion & Impact:Biochemical abnormalities were sometimes different in our patients in comparison to previous studies, possibly due to the delay in the diagnosis in our patients.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Hepatolentiküler dejenerasyon · İran · Genetik hastalıklar

Abstract

Background/aims: Wilson disease is an autosomal recessive disorder of the brain, liver and cornea. It is fatal if left untreated. This descriptive study attempted to identify the demographic, clinical, and biochemical features of Wilson disease in Fars Province, Southern Iran. Methods: All the patients with Wilson disease who were admitted to Nemazee Hospital, Shiraz, Iran, from 1990 till 2004 were included in this cross-sectional descriptive study. This is the only hospital in Southern Iran which has pediatric and adult Gastroenterology Wards. Statistical analyses were done by t-test. Results: In total, 111 patients were studied (65 males, 46 females). The mean age was 11±7 years; the youngest was three years old. The most common manifestations were hepatic (83.8%), neurological (24.3%) and psychological (23.4%) signs and symptoms. The most common biochemical abnormalities were increased urinary copper (91.4%), increased prothrombin time (84.5%), increased liver enzymes (77-89%), decreased serum ceruloplasmin (75.5%), hyperbilirubinemia (67%) and anemia (62.4%). Family history was positive in 36% of the patients. Conclusions: In this study, sex ratio (M/F) was greater than one, similar to other studies. Age range was similar to other Asian studies, but less than observed in European and American studies. Clinical manifestations of Wilson disease in our patients were similar to the studies with similar age ranges. Biochemical abnormalities were sometimes different in our patients in comparison to previous studies, possibly due to the delay in the diagnosis in our patients.

Özet

Amaç: Wilson hastalığı beyin, karaciğer ve korneanın otozomal ressesiv hastalığıdır. Tedavisiz ölümcüldür. Bu deskriptif çalışma, Güney İran’da Fars eyaletindeki Wilson hastalarının demografik, klinik ve biokimyasal özelliklerini tespit etmeye yöneliktir. Yöntem: Bu "cross-sectional" deskriptif çalışmaya 1990- 2004 yılları arasında Nemazee Hastanesine (fiiraz, Iran) yatan ve Wilson hastalığı tanısı alan tüm hastalar dahil edildi. Bu hastane Güney İran’da pediatri ve adült gastroenteroloji klinikleri barındıran tek hastanedir. İstatistiki analizle t-testiyle yapı ldı. Bulgular: Toplam 111 hasta çalışmaya alındı (65 erkek ve 46 bayan). Ortalama yaşları 11±7 yaştı ve en genç hasta 3 yaşındaydı. En sık hastalık belirtileri şöyle sıralanıyordu: Hepatik (%83.8), nörolojik (%24.3) ve psikolojik bulgular ve semptomlar (%23.4). En sık görülen biokimyasal bozukluklar artmış idrar bakırı (%91.4), düşük serum seruloplazmin (%75.5), hiperbilirubinemi (%67) ve anemiydi (%62.4). Hastaların %36’sında pozitif aile öyküsü mevcuttu. Sonuç: Bu çalışmada kadın/erkek oranı başka çalışmalara uygun biçimde 1’den fazlaydı. Hasta yaşı dağılımı diğer Asya çalışmalarına uygundu, fakat Amerika ve Avrupa’dan bildirilenlere göre daha düşüktü. Wilson hastalığı klinik belirtileri benzer yaş grupları içeren çalı şmalarınkine uygunluk gösteriyordu. Biokimyasal değişiklikler, başka çalışmalara göre bazen farklılık gösteriyordu; bu muhtemelen hastalarımızda geç tanı konması ile ilgili olabilir.

🔖

Cite This Article

POOYA, A. A., ESLAMI, N. S., HAGHIGHAT, M. (2005). Güney İran'da Wilson hastalığı. Turkish Journal of Gastroenterology, Cilt: 16 - Sayı: 2, 71–74. https://ajindex.com/articles/410892

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Rudolph JA, Balistreri WF. Metabolic diseases of the liver. In: Behrman RE, et al. (eds). Nelson Textbook of Pediatrics, 17th ed. Philadelphia: Saunders, 2004: 1321-2. 2.Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003; 37(6): 1475-92. 3. Gitlin JD. Wilson disease. Gastroenterology 2003; 125(6): 1868-77. 4.Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23(3): 139-42. 5.Wu ZY, Lin MT, Murong SX, et al. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease. Arch Neurol 2003; 60(5): 737-41. 6.Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987; 146: 261-5. 7.Ozsoylu S, Kocak N. Wilson disease in Turkish children. Eur J Pediatr 1988; 147 (3): 334. 8.Chiauzzi R, Cunego A, De Luca D. Studio epidemiologic sul morbo di Wilson. G Clin Med 1980; 61: 284-96. 9.Amira M, Sano IG.enetic studies of Wilson’s disease in Japan. Birth Defects 1968; 4: 54-9. 10.Bachmann H, Lobner J, Biesold D. Untersuchungen zur Wilsonschen Erkrankung in der DDR. Teil I: Genetik und Epidemiologie. Z Gesamte Inn Med 1979; 34: 744-8. 11.Bearn AG. A genetical analysis of thirty families with Wilson’s disease (hepatolenticular degeneration). Ann Hum Genet 1960; 24: 33-43. 12.Sternlieb I, Scheinberg IH. Prevention of Wilson’s disease in asymptomatic patients. N Engl J Med 1968; 278: 352-9. 13.Dasur DK, Manghani DK, Wadia NH. Wilson’s disease in India. Geographic genetic and clinical aspects in 16 families. Neurology 1968; 18: 21-31. 14.Strickland GT, Frommer D, Leu ML, et al. Wilson’s disease in the United Kingdom and Taiwan. Q J Med 1973; 42: 619-38. 15.Stremmel W, Meyerrose KW, Niederau C, et al. Wilson disease: Clinical presentation, treatment, and survival. Ann Intern Med 1991; 115(9): 720-6. 16.Yuce A, Kocak N, Demir H, et al. Evaluation of diagnostic parameters of Wilson's disease in childhood. Indian J Gastroenterol 2003; 22(1): 4-6. 17. Datta S, Datta H. Kayser–Fleischer ring. Indian Pediatr 2004; 41(7): 744. 18.Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28(Suppl 1): 28-36. 19. Roberts EA, Cox DW. Wilson disease. Baillieres Clin Gastroenterol 1998; 12(2): 237-56.